Your session is about to expire
← Back to Search
Active MIDCAB for Foot Surgery (MIDCAB Trial)
MIDCAB Trial Summary
This trial is testing a new way to numb the area around the ankle and foot during surgery, which may provide better pain relief and allow patients to move their foot during surgery and recovery.
- Foot Surgery
- Ankle Surgery
MIDCAB Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MIDCAB Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Active MIDCAB
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the eligibility criteria for this trial encompass individuals below 35 years of age?
"This clinical trial is recruiting individuals aged between 18 and 80."
Are there any criteria that participants must fulfill to partake in this trial?
"This human trial demands that 20 volunteers aged 18-80 meet the prerequisites of using regional anesthesia, following protocol instructions and having foot or angle surgery."
Are there currently openings for this clinical testing?
"Affirmative. Clinicaltrials.gov confirms that this investigation, which was originally announced on July 21st 2022 is presently recruiting for 20 volunteers from one setting."
What potential risks may patients incur from this treatment regimen?
"This treatment has been granted approval, so its safety rating is 3 on the Power team's scale. As a Phase 4 trial, this medicinal intervention can be safely administered to patients."
How many individuals are being recruited for this experiment?
"Indeed, the clinicaltrials.gov portal states that this study is actively recruiting participants. This medical research was initially posted on July 21st 2022 and most recently modified on October 27th 2022; it seeks to recruit 20 individuals from a single site."
Share this study with friends
Copy Link
Messenger